Figure 5.
Odds ratio of neurological and psychiatric outcomes in COVID-19 patients with Type I IFN treatment compared to COVID-19 patients without Type I IFN treatment, 1 day to anytime afterwards.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.